Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial)
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This is a multi-national trial. The goals of the trial are to study LUM-201 as a possible
treatment for Pediatric Growth Hormone Deficiency (PGHD) and investigate a predictive
enrichment marker (PEM) strategy to select subjects likely to respond to therapy with
LUM-201.